Association between level of platelet inhibition after early use of Abciximab and myocardial reperfusion in ST-elevation acute myocardial infarction treated by primary percutaneous coronary intervention

American Journal of Cardiology

Volumn 97, Issue 6, 2006, Pages 798-803

  Pérez De Prado, Armando ^a   Fernández Vázquez, Felipe ^a   Cuellas, J Carlos ^a   Alonso Orcajo, Norberto ^a   Carbonell, Raúl ^a   Pascual, Cristina ^a   Olalla, Cristina ^a   Diego, Alejandro ^a   De Miguel, Antonio ^a   Calabozo, Ramón G ^a  

^a HOSPITAL DE LEÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; HEPARIN;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; CONTROLLED STUDY; DRUG RESPONSE; ELECTROCARDIOGRAM; FEMALE; HEART MUSCLE REPERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION; STATISTICAL ANALYSIS; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; TREATMENT OUTCOME;

AGED; ANTIBODIES, MONOCLONAL; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PLATELET AGGREGATION INHIBITORS; TREATMENT OUTCOME;

EID: 33644584430     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.10.019     Document Type: Article

References (30)

1. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction ISIS-2 Lancet 2 1988 349 360
2. W.D. Weaver, R.J. Simes, A. Betriu, C.L. Grines, F. Zijlstra, E. Garcia, L. Grinfeld, R.J. Gibbons, E.E. Ribeiro, M.A. DeWood, F. Ribichini Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction a quantitative review JAMA 278 1997 2093 2098
3. A.S. Petronio, D. Rovai, G. Musumeci, R. Baglini, C. Nardi, U. Limbruno, C. Palagi, D. Volterrani, M. Mariani Effects of abciximab on microvascular integrity and left ventricular functional recovery in patients with acute infarction treated by primary coronary angioplasty Eur Heart J 24 2003 67 76
4. C.M. Gibson, J.A. de Lemos, S.A. Murphy, S.J. Marble, C.H. McCabe, C.P. Cannon, E.M. Antman, E. Braunwald Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction a TIMI 14 substudy Circulation 103 2001 2550 2554
5. F.J. Neumann, R. Blasini, C. Schmitt, E. Alt, J. Dirschinger, M. Gawaz, A. Kastrati, A. Schomig Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction Circulation 98 1998 2695 2701
6. D. Antoniucci, A. Migliorini, G. Parodi, R. Valenti, A. Rodriguez, A. Hempel, G. Memisha, G.M. Santoro Abciximab-supported infarct artery stent implantation for acute myocardial infarction and long-term survival a prospective, multicenter, randomized trial comparing infarct artery stenting plus abciximab with stenting alone Circulation 109 2004 1704 1706
7. G.W. Stone, C.L. Grines, D.A. Cox, E. Garcia, J.E. Tcheng, J.J. Griffin, G. Guagliumi, T. Stuckey, M. Turco, J.D. Carroll Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction N Engl J Med 346 2002 957 966
8. G. Montalescot, P. Barragan, O. Wittenberg, P. Ecollan, S. Elhadad, P. Villain, J.M. Boulenc, M.C. Morice, L. Maillard, M. Pansieri Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction N Engl J Med 344 2001 1895 1903
9. G. Montalescot, M. Borentain, L. Payot, J.P. Collet, D. Thomas Early vs late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction a meta-analysis JAMA 292 2004 362 366
10. J.E. Tcheng, S.G. Ellis, B.S. George, D.J. Kereiakes, N.S. Kleiman, J.D. Talley, A.L. Wang, H.F. Weisman, R.M. Califf, E.J. Topol Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty Circulation 90 1994 1757 1764
11. M.J. Quinn, R.T. Murphy, M. Dooley, J.B. Foley, D.J. Fitzgerald Occupancy of the internal and external pools of glycoprotein IIb/IIIa following abciximab bolus and infusion J Pharmacol Exp Ther 297 2001 496 500
12. S.R. Steinhubl, J.D. Talley, G.A. Braden, J.E. Tcheng, P.J. Casterella, D.J. Moliterno, F.I. Navetta, P.B. Berger, J.J. Popma, G. Dangas Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention results of the GOLD (AU-Assessing Ultegra) multicenter study Circulation 103 2001 2572 2578
13. C.M. Gibson, L.K. Jennings, S.A. Murphy, D.P. Lorenz, R.P. Giugliano, R.A. Harrington, S. Cholera, R. Krishnan, R.M. Califf, E. Braunwald Association between platelet receptor occupancy after eptifibatide (integrilin) therapy and patency, myocardial perfusion, and ST-segment resolution among patients with ST-segment-elevation myocardial infarction an INTEGRITI (Integrilin and Tenecteplase in Acute Myocardial Infarction) substudy Circulation 110 2004 679 684
14. M. Frossard, I. Fuchs, J.M. Leitner, K. Hsieh, M. Vlcek, H. Losert, H. Domanovits, W. Schreiber, A.N. Laggner, B. Jilma Platelet function predicts myocardial damage in patients with acute myocardial infarction Circulation 110 2004 1392 1397
15. N.M. Ernst, H. Suryapranata, K. Miedema, R.J. Slingerland, J.P. Ottervanger, J.C. Hoorntje, A.T. Gosselink, J.H. Dambrink, M.J. de Boer, F. Zijlstra, A.W. van't Hof Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction J Am Coll Cardiol 44 2004 1187 1193
16. G.L. Wheeler, G.A. Braden, S.R. Steinhubl, D.J. Kereiakes, K. Kottke-Marchant, A.D. Michelson, M.I. Furman, M.N. Mueller, D.J. Moliterno, D.C. Sane The Ultegra rapid platelet-function assay comparison to standard platelet function assays in patients undergoing percutaneous coronary intervention with abciximab therapy Am Heart J 143 2002 602 611
17. J.W. Smith, S.R. Steinhubl, A.M. Lincoff, J.C. Coleman, T.T. Lee, R.S. Hillman, B.S. Coller Rapid platelet-function assay an automated and quantitative cartridge-based method Circulation 99 1999 620 625
18. A.W. van't Hof, A. Liem, M.J. de Boer, F. Zijlstra Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle Myocardial infarction Study Group Lancet 350 1997 615 619
19. R. Schroder, K. Wegscheider, K. Schroder, R. Dissmann, W. Meyer-Sabellek Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial J Am Coll Cardiol 26 1995 1657 1664
20. R. Schroder, R. Dissmann, T. Bruggemann, K. Wegscheider, T. Linderer, U. Tebbe, K.L. Neuhaus Extent of early ST segment elevation resolution a simple but strong predictor of outcome in patients with acute myocardial infarction J Am Coll Cardiol 24 1994 384 391
21. S. Matetzky, M. Novikov, L. Gruberg, D. Freimark, M. Feinberg, D. Elian, I. Novikov, E. Di Segni, O. Agranat, Y. Har-Zahav The significance of persistent ST elevation versus early resolution of ST segment elevation after primary PTCA J Am Coll Cardiol 34 1999 1932 1938
22. M.J. Claeys, J. Bosmans, L. Veenstra, P. Jorens, H. De Raedt, C.J. Vrints Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction importance of microvascular reperfusion injury on clinical outcome Circulation 99 1999 1972 1977
23. A.W. van't Hof, A. Liem, H. Suryapranata, J.C. Hoorntje, M.J. de Boer, F. Zijlstra Zwolle Myocardial Infarction Study Group Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction myocardial blush grade Circulation 97 1998 2302 2306
24. C.M. Gibson, C.P. Cannon, S.A. Murphy, K.A. Ryan, R. Mesley, S.J. Marble, C.H. McCabe, F. Van De Werf, E. Braunwald Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs Circulation 101 2000 125 130
25. TIMI Study Group The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings N Engl J Med 312 1985 932 936
26. C.M. Gibson, S.A. Murphy, M.J. Rizzo, K.A. Ryan, S.J. Marble, C.H. McCabe, C.P. Cannon, F. Van de Werf, E. Braunwald Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study Group Circulation 99 1999 1945 1950
27. C.M. Gibson, C.P. Cannon, W.L. Daley, J.T. Dodge, B. Alexander, S.J. Marble, C.H. McCabe, L. Raymond, T. Fortin, W.K. Poole, E. Braunwald TIMI frame count a quantitative method of assessing coronary artery flow Circulation 93 1996 879 888
28. L.J. Feldman, P. Coste, A. Furber, P. Dupouy, M.S. Slama, J.P. Monassier, C. Tron, A. Lafont, M. Faraggi, D. Le Guludec Incomplete resolution of ST-segment elevation is a marker of transient microcirculatory dysfunction after stenting for acute myocardial infarction Circulation 107 2003 2684 2689
29. A. Poli, R. Fetiveau, P. Vandoni, G. del Rosso, M. D'Urbano, G. Seveso, F. Cafiero, S. De Servi Integrated analysis of myocardial blush and ST-segment elevation recovery after successful primary angioplasty real-time grading of microvascular reperfusion and prediction of early and late recovery of left ventricular function Circulation 106 2002 313 318
30. P. Buszman, A. Szafranek, Z. Kalarus, M. Gasior Use of changes in ST segment elevation for prediction of infarct artery recanalization in acute myocardial infarction Eur Heart J 16 1995 1207 1214